Matches in Wikidata for { <http://www.wikidata.org/entity/Q64448958> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q64448958 description "2012 թվականի մարտի 10-ին հրատարակված գիտական հոդված" @default.
- Q64448958 description "artículu científicu espublizáu en marzu de 2012" @default.
- Q64448958 description "im Mai 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64448958 description "scientific article published on 10 March 2012" @default.
- Q64448958 description "wetenschappelijk artikel" @default.
- Q64448958 description "наукова стаття, опублікована в травні 2012" @default.
- Q64448958 name "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 name "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 type Item @default.
- Q64448958 label "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 label "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 prefLabel "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 prefLabel "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 P1433 Q64448958-82C0E40B-4906-4A93-B444-99D4E3EDDE9B @default.
- Q64448958 P1476 Q64448958-BC474E57-8BCB-46E6-8FF1-FB2CD7270AC6 @default.
- Q64448958 P2093 Q64448958-0C65169B-0C1B-46C9-AC60-0B8F2A669010 @default.
- Q64448958 P2093 Q64448958-28B0D67D-FE43-4ADE-839C-7330A3C958B5 @default.
- Q64448958 P2093 Q64448958-388B4F20-DAFE-41CA-87E2-C04A7792D22B @default.
- Q64448958 P2093 Q64448958-532D93A6-1598-4826-862B-4B71A8FA0DB5 @default.
- Q64448958 P2093 Q64448958-5A810F56-F046-4956-BDD2-A26EA2CB3A4D @default.
- Q64448958 P2093 Q64448958-5EC26247-8919-45E8-A14F-559C3081899A @default.
- Q64448958 P2093 Q64448958-665B4538-894D-4DD2-925B-C37B475A8DCF @default.
- Q64448958 P2093 Q64448958-6EFC0121-3F11-45BE-AFD6-3CEAA6F6C10C @default.
- Q64448958 P2093 Q64448958-930C08F6-CF8B-4596-9551-13DE9D12D83A @default.
- Q64448958 P2093 Q64448958-AC402810-D2A5-40F3-9BD5-7783C5F4EC88 @default.
- Q64448958 P2093 Q64448958-D22E0039-A170-4E30-AD15-E1FC75FBCC34 @default.
- Q64448958 P2093 Q64448958-E7A4B2BF-53E9-436F-826A-7D24AD84CCA9 @default.
- Q64448958 P2093 Q64448958-EDB5F0A5-68FC-4228-9DF7-DEE581E984B4 @default.
- Q64448958 P2093 Q64448958-F7D869B9-5A14-4F4D-BE29-03B9CCAAB6FE @default.
- Q64448958 P304 Q64448958-B7AE0A47-77A4-42C2-87A7-AD44EE1C8BA7 @default.
- Q64448958 P31 Q64448958-42980F23-1D9A-4319-9F32-D05254B915EE @default.
- Q64448958 P356 Q64448958-F8CACEEE-F687-465C-ACEA-62892087933C @default.
- Q64448958 P407 Q64448958-AD053191-8B78-4284-89C6-06F245270455 @default.
- Q64448958 P433 Q64448958-A2C0E5A5-BD62-4518-AB34-35133433FC83 @default.
- Q64448958 P478 Q64448958-EAA4A4C2-A941-4426-8CAF-35CA5AC0CA88 @default.
- Q64448958 P50 Q64448958-7AFC8151-225C-477E-8F66-AA8AEE83FF05 @default.
- Q64448958 P577 Q64448958-6689210F-D2C9-40F5-8417-0E8A988BABD3 @default.
- Q64448958 P698 Q64448958-ACB1EF9D-0373-4071-8AD9-E840E2AEC093 @default.
- Q64448958 P921 Q64448958-56AF0CD4-0808-4046-91F8-8B00A3907591 @default.
- Q64448958 P356 J.EJCA.2012.02.050 @default.
- Q64448958 P698 22409947 @default.
- Q64448958 P1433 Q332260 @default.
- Q64448958 P1476 "Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma" @default.
- Q64448958 P2093 "Avishay Sella" @default.
- Q64448958 P2093 "Avivit Peer" @default.
- Q64448958 P2093 "Ben Boursi" @default.
- Q64448958 P2093 "Daniel Keizman" @default.
- Q64448958 P2093 "Hans Hammers" @default.
- Q64448958 P2093 "Henry Hayat" @default.
- Q64448958 P2093 "Mario A Eisenberger" @default.
- Q64448958 P2093 "Maya Gottfried" @default.
- Q64448958 P2093 "Michael A Carducci" @default.
- Q64448958 P2093 "Natalie Maimon" @default.
- Q64448958 P2093 "Raanan Berger" @default.
- Q64448958 P2093 "Roberto Pili" @default.
- Q64448958 P2093 "Svetlana Kovel" @default.
- Q64448958 P2093 "Victoria Sinibaldi" @default.
- Q64448958 P304 "1031-1037" @default.
- Q64448958 P31 Q13442814 @default.
- Q64448958 P356 "10.1016/J.EJCA.2012.02.050" @default.
- Q64448958 P407 Q1860 @default.
- Q64448958 P433 "7" @default.
- Q64448958 P478 "48" @default.
- Q64448958 P50 Q59157787 @default.
- Q64448958 P577 "2012-03-10T00:00:00Z" @default.
- Q64448958 P698 "22409947" @default.
- Q64448958 P921 Q1164529 @default.